Period Ending | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 |
---|
Total Revenue
|
14,414,000
|
9,664,000
|
11,864,000
| Cost of Revenue | 11,184,000 | 7,397,000 | 7,954,000 | |
Gross Profit
|
3,230,000
|
2,267,000
|
3,910,000
| |
|
Operating Expenses |
|
Research Development | 429,000 | 397,000 | 426,000 |
|
Selling General and Administrative | 1,250,000 | 1,120,000 | 1,046,000 |
|
Non Recurring | 134,000 | 18,000 | 62,000 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
1,417,000
|
732,000
|
2,376,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 6,000 | 4,000 | 30,000 |
|
Earnings Before Interest And Taxes | 1,282,000 | 611,000 | 2,408,000 |
|
Interest Expense |
-
|
-
| 89,000 |
|
Income Before Tax | 1,282,000 | 611,000 | 2,319,000 |
|
Income Tax Expense | 463,000 | 190,000 | 684,000 |
|
Minority Interest | (7,000) |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 812,000 | 421,000 | 1,635,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
812,000
|
421,000
|
1,635,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
812,000
|
421,000
|
1,635,000
|
|